Mid Atlantic Retina is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Mid Atlantic Retina has participated in 42 clinical trials with 10 currently active.
Therapeutic areas: Geographic Atrophy Secondary to Age-related Macular Degeneration, Symptomatic Vitreomacular Adhesion, Choroidal Neovascularization.
Sponsors: Novartis Pharmaceuticals, ThromboGenics, Hoffmann-La Roche.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mid Atlantic Retina has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mid Atlantic Retina has 42 clinical trials on record, with 10 currently active. Their work covers Geographic Atrophy Secondary to Age-related Macular Degeneration, Symptomatic Vitreomacular Adhesion, Choroidal Neovascularization.
Mid Atlantic Retina has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.